"Julie Schwartzbard, MD is board-certified in Neurology. She is fellowship-trained in neuromuscular disorders and performs nerve conduction studies and electromyography. She also specializes in dementia, migraine headaches, Parkinson’s disease, vertigo, stroke, and epilepsy. In addition to her private practice, she is involved in multiple clinical trials investigating new treatments for various neurological disorders including dementia, Parkinson’s disease, and migraine headaches. Dr. Schwartzbard is on the voluntary faculty of the University of Miami where she assists with teaching the residents in training. She also teaches medical students who rotate through her Aventura office."

During the past decade, Aventura Neurological Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aventura Neurological Associates" #1 collaborator was "Prothena Biosciences Limited" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Aventura Neurological Associates" are "Episodic Migraine" (2 trials), "Migraine, With or Without Aura" (1 trials), "Parkinson's Disease" (1 trials) and "Parkinsons Disease" (1 trials). Many other conditions were trialed in "Aventura Neurological Associates" in a lesser frequency.

Most popular intervention types in "Aventura Neurological Associates" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atogepant" (2 trials), "Placebo-matching Ubrogepant" (1 trials), "Prasinezumab" (1 trials) and "RO7046015" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aventura Neurological Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Aventura Neurological Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aventura Neurological Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aventura Neurological Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".